Finding sustainable solutions to chronic diseases and providing the best health services to community members is a priority and of major concern for the Ministry of Health and Prevention (MoHAP) and the Emirates Health Services (EHS). From this standpoint, the two entities recently revealed innovative immunotherapy for cancer and viral infections in cooperation with Japan’s Kyoto University.
This came during the participation of the ministry and the EHS at the Arab Health 2021 which takes place in Dubai from 21-24.
The treatment is based on the clinical application of the therapy using T cell preparation. It was found such type of cells has the ability to fight cancer and viral infections. The T cell medicine will be produced using the iPS cell technology.
T Cell makes up a group of lymphocytes present in the blood and plays a major role in cellular immunity. It's possible to produce T cells in large numbers store them in appropriate conditions to be administered to patients when needed.
Thus, by the success of this project, patients having cancer or viral infection may have great merit in which they can make very easy access to T cell therapy.
HE Dr. Youssef Mohamed Al Serkal, Director-General of the Emirates Health Services, spoke about the commitment of the ministry and the EHS to having strategic partnerships with the most prestigious medical research centers, while keeping an eye on the sustainable investment in future healthcare services.
Although cancer prevalence in the UAE is considered lower than in other parts of the world, we work hard to make a qualitative shift in cancer and viral infection healthcare, Al Serkal noted. This is part of our strategy to provide healthcare services in innovative and sustainable ways and implement the national strategy to reduce cancer mortality rates, he added.
Al Serkal pointed out that the ministry and EHS support the National Cancer Control Program and prepare a road map to achieve the target indicator. They also analyze the current status of cancer diseases and their diagnostic and therapeutic pathways, underpin research and studies on the control of cancer diseases and viral infections, and support workshops and educational and training activities. awareness campaigns, and innovative initiatives.
Improving health and wellbeing of patients
Dr. Kalthum Al Balushi, Director of Hospitals Department, said: The groundbreaking treatment technology for cancer and viral infections, in cooperation with the Kyoto University, represents a paradigm shift in health services provided by the Ministry and the EHS.
Al Balushi added that the treatment is based on stimulating immune cells to fight cancer cells using pluripotent stem cells, which is a recent global trend that has begun to open great prospects for improving the quality of life of patients.